Riber (ALRIB) Q4 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 TU earnings summary
27 Mar, 2026Executive summary
Full-year 2025 revenues reached €40.3 million, aligning with guidance and reflecting strong production system activity and the initial rollout of the ROSIE platform.
The order book at year-end 2025 stood at €26.9 million, up 24% year-over-year, indicating robust future demand.
Financial highlights
Total revenues for 2025 were €40.3 million, a slight decrease of 2% compared to 2024.
MBE systems revenues were stable at €30.9 million, with 12 machines invoiced, including 9 production systems and the first ROSIE platform.
Services and accessories revenue was €9.4 million, down 8% year-over-year, but showed an 8.5% recovery in the second half.
European revenue share increased to 45.1%, while Asia declined to 39.7% and North America rose to 15.2%.
Outlook and guidance
Anticipates continued strong demand in 2026, driven by MBE production systems for quantum dot lasers and the ramp-up of the ROSIE platform.
Expects revenue growth in 2026, contingent on export license approvals.
Key milestones include manufacturing the ROSIE 2 dual-chamber version and delivering BTO/STO thin film samples.
Latest events from Riber
- Revenues grew 13% and the order book rose 18%, signaling robust semiconductor market demand.ALRIB
Q2 2024 TU27 Mar 2026 - Solid H1 2024 growth: revenues up 13%, net profit positive, and order book up 18%.ALRIB
H1 202427 Mar 2026 - Revenues up 14% and order book up 14% year-over-year, with strong outlook for full-year growth.ALRIB
Q3 2024 TU27 Mar 2026 - 2024 revenues rose 5% to €41.2m, with further growth expected in 2025.ALRIB
Q4 2024 TU27 Mar 2026 - Revenue and net income rose, but order book fell 17% amid economic uncertainty.ALRIB
H2 202427 Mar 2026 - First-half 2025 revenue fell 22%, but full-year revenue is expected to surpass €40m.ALRIB
Q2 2025 TU27 Mar 2026 - H1 2025 revenues fell, but a strengthened order book and tech milestones support >€40m target.ALRIB
H1 202527 Mar 2026